Asian Journal of Microbiology and Biotechnology

Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (London, England). 1971;1(7712):1253-7. DOI: 10.1016/s0140-6736(71)91776-4

Calvignac-Spencer S, Feltkamp MC, Daugherty MD, Moens U, Ramqvist T, Johne R et al. A taxonomy update for the family Polyomaviridae. Arch Virol. 2016;161(6):1739-50. DOI: 10.1007/s00705-016-2794-y

Moens U, Calvignac-Spencer S, Lauber C, Ramqvist T, Feltkamp MCW, Daugherty MD et al. ICTV Virus Taxonomy Profile: Polyomaviridae. The Journal of general virology. 2017;98(6):1159-60. DOI: 10.1099/jgv.0.000839

Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. Journal of medical virology. 1982;10(2):91-9.

DOI: 10.1002/jmv.1890100203

Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies. Clin Microbiol Rev. 2017;30(2):503-28. DOI: 10.1128/CMR.00074-16

IARC. Malaria and Some Polymaviruses (SV40, BK, JC, AND Merkel Cell viruses). IARC Monographs on the evaluation of Carcinogenic Risk to Humans.Lyon, France: International Agency for Research on Cancer (IARC) monographs on the evaluation of carcinogenic risks to humans; 2012.

Hirsch HH, J. S. Polyomavirus BK. The Lancet Infectious Diseases. 2003;3:611–23.

Heritage J, Chesters PM, McCance DJ. The persistence of papovavirus BK DNA sequences in normal human renal tissue. Journal of Medical Virology. 1981;8(2):143-50. DOI: 10.1002/jmv.1890080208

Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. The Journal of Infectious Diseases. 1983;147(4):676-84. doi:10.1093/infdis/147.4.676.

Hogan TF, Padgett BL, Walker DL, Borden EC, McBain JA. Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy. Journal of Clinical Microbiology. 1980;11(2):178-83.

DOI: 10.1128/jcm.11.2.178-183.1980

Shinohara T, Matsuda M, Cheng SH, Marshall J, Fujita M, Nagashima K. BK virus infection of the human urinary tract. Journal of medical virology. 1993;41(4): 301-5. DOI: https://doi.org/10.1002/jmv.1890410408

Boldorini R, Veggiani C, Barco D, Monga G. Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies. Archives of pathology & laboratory medicine. 2005;129(1):69-73. DOI: 10.5858/2005-129-69-KAUTPI

Singh HK, Bubendorf L, Mihatsch MJ, Drachenberg CB, Nickeleit V. Urine Cytology Findings of Polyomavirus Infections. In: Ahsan N, editor. Polyomaviruses and Human Diseases. New York, NY: Springer New York. 2006;201-12.

Sundsfjord A, Flaegstad T, Flø R, Spein AR, Pedersen M, Permin H et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. The Journal of infectious diseases. 1994;169(3):485-90. DOI:10.1093/infdis/169.3.485

Jin L, Pietropaolo V, Booth JC, Ward KH, Brown DW. Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis. Clinical and diagnostic virology. 1995;3(3):285-95. DOI: 10.1016/s0928-0197(94)00044-1

Dalianis T, Ljungman P. Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients. Anticancer Research. 2011;31(3):939-44.

Hirsch HH, Randhawa P. BK virus in solid organ transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009;9 Suppl 4:S136-46. DOI: 10.1111/j.1600-6143.2009.02904.x

Vallbracht A, Löhler J, Gossmann J, Glück T, Petersen D, Gerth HJ et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. The American Journal of Pathology. 1993; 143(1):29-39.

Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM. BK virus DNA in CSF of immunocompetent and immunocompromised patients. Archives of Disease in Childhood. 2003;88(2):174-5.

DOI: 10.1136/adc.88.2.174

Jørgensen GEK, Hammarin A-L, Bratt G, Grandien M, Flægstad T, Johnsen JI. Identification of a unique BK virus variant in the CNS of a patient with AIDS. Journal of Medical Virology. 2003;70(1):14-9.

DOI: https://doi.org/10.1002/jmv.10370

Prado JCM, Monezi TA, Amorim AT, Lino V, Paladino A, Boccardo E. Human polyomaviruses and cancer: An overview. Clinics (Sao Paulo, Brazil). 2018;73(suppl 1):e558s. DOI: 10.6061/clinics/2018/e558s

Brooks G, Carroll K, Butel J, Morse S, T. M. Medical Microbiology. New York: McGraw-Hill; 2013.

Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471-506. DOI: 10.1128/cmr.05031-1

Seehafer J, Salmi A, Scraba DG, JS. C. A comparative study of BK and polyoma viruses. Virology. 1975;66 192–205.

Rayment I, Baker TS, Caspar DL, WT M. Polyoma virus capsid structure at 22.5 A resolution. Nature. 1982;295:110–5.

Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, SC. H. Structure of simian virus 40 at 3.8-A resolution. Nature. 1991;354:278–84.

Hurdiss DL, Morgan EL, Thompson RF, Prescott E M, Panou M, A M et al. New Structural Insights into the Genome and Minor Capsid Proteins of BK Polyomavirus using Cryo-Electron Microscopy. Structure (London, England: 1993). 2016;24:528–36.

Strauss EG, JH. S. Viruses and human disease. California, USA: Elsevier; 2007.

Lee S, Paulson KG, Murchison EP, Afanasiev OK, Alkan C, Leonard JH et al. Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2011;52(3): 272-5.

DOI: 10.1016/j.jcv.2011.08.012

Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell host & Microbe. 2011;9(2):93-102. DOI: 10.1016/j.chom.2011.01.008

Tognon M, Corallini A, Martini F, Negrini M, Barbanti-Brodano G. Oncogenic transformation by BK virus and association with human tumors. Oncogene. 2003; 22(33):5192-200. DOI: 10.1038/sj.onc.1206550

White MK, Khalili K. Polyomaviruses and human cancer: Molecular mechanisms underlying patterns of tumorigenesis. Virology. 2004;324(1):1-16. DOI: 10.1016/j.virol.2004.03.025

Fioriti D, Videtta M, Mischitelli M, Degener AM, Russo G, Giordano A et al. The human polyomavirus BK: Potential role in cancer. Journal of Cellular Physiology. 2005;204(2):402-6. DOI: 10.1002/jcp.20300

Corallini A, Tognon M, Negrini M, Barbanti-Brodano G. Evidence for BK Virus as a Human Tumor Virus. In: Corallini, editor. Human Polyomaviruses: Molecular and Clinical Perspectives. New York, USA: John Wiley & Sons, Inc; 2002.

Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Seminars in Cancer Biology. 2009;19(4):252-60. DOI: 10.1016/j.semcancer.2009.02.004

Tognon M, Provenzano M. New insights on the association between the prostate cancer and the small DNA tumour virus, BK polyomavirus. Journal of Translational Medicine. 2015;13:387. DOI: 10.1186/s12967-015-0754-z

Pastrana DV, Ray U, Magaldi TG, Schowalter RM, Çuburu N, Buck CB. BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism. Journal of virology. 2013;87(18):10105-13. DOI: 10.1128/jvi.01189-13

Low JA, Magnuson B, Tsai B, Imperiale MJ. Identification of gangliosides GD1b and GT1b as receptors for BK virus. Journal of Virology. 2006;80(3):1361-6. DOI: 10.1128/jvi.80.3.1361-1366.2006

Dugan AS, Eash S, Atwood WJ. An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. Journal of Virology. 2005;79(22):14442-5. DOI: 10.1128/JVI.79.22.14442-14445.2005

Dugan AS, Eash S, Atwood WJ. Update on BK virus entry and intracellular trafficking. Transplant infectious disease: An official journal of the Transplantation Society. 2006;8(2):62-7. DOI: 10.1111/j.1399-3062.2006.00153.x

Neu U, Allen SA, Blaum BS, Liu Y, Frank M, Palma AS et al. A structure-guided mutation in the major capsid protein retargets BK polyomavirus. PLoS Pathogens. 2013;9(10):e1003688. DOI: 10.1371/journal.ppat.1003688

Eash S, Querbes W, Atwood WJ. Infection of vero cells by BK virus is dependent on caveolae. Journal of Virology. 2004;78(21): 11583-90. DOI: 10.1128/jvi.78.21.11583-11590.2004.

Moriyama T, Marquez JP, Wakatsuki T, Sorokin A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. Journal of Virology. 2007;81(16):8552-62. DOI: 10.1128/jvi.00924-07.

Moriyama T, Sorokin A. Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin. Transplantation. 2008;85(9): 1311-7. DOI: 10.1097/TP.0b013e31816c4ec5

Zhao L, Marciano AT, Rivet CR, Imperiale MJ. Caveolin- and clathrin-independent entry of BKPyV into primary human proximal tubule epithelial cells. Virology. 2016;492:66-72. DOI: 10.1016/j.virol.2016.02.007.

Drachenberg CB, Papadimitriou JC, Wali R, Cubitt CL, Ramos E. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2003;3(11):1383-92.

DOI: 10.1046/j.1600-6135.2003.00237.x

Moriyama T, Sorokin A. Intracellular trafficking pathway of BK Virus in human renal proximal tubular epithelial cells. Virology. 2008;371(2):336-49. DOI: 10.1016/j.virol.2007.09.030

Jiang M, Abend JR, Tsai B, Imperiale MJ. Early events during BK virus entry and disassembly. Journal of Virology. 2009; 83(3):1350-8. DOI: 10.1128/jvi.02169-08

Maru S, Jin G, Desai D, Amin S, Shwetank, Lauver MD et al. Inhibition of Retrograde Transport Limits Polyomavirus Infection in vivo. mSphere. 2017;2(6). DOI: 10.1128/mSphereDirect.00494-17

Dupzyk A, Tsai B. How Polyomaviruses Exploit the ERAD Machinery to Cause Infection. Viruses. 2016;8(9).

DOI: 10.3390/v8090242

Bennett SM, Zhao L, Bosard C, Imperiale MJ. Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry. Virology. 2015;474: 110-6. DOI: 10.1016/j.virol.2014.10.013.

Cubitt CL. Molecular genetics of the BK virus. Advances in experimental medicine and biology. 2006;577:85-95.

DOI: 10.1007/0-387-32957-9_6

Pater MM, Pater A, di Mayorca G, Beth E, Giraldo G. BK virus-transformed inbred hamster brain cells: status of viral DNA in subclones. Molecular and cellular biology. 1982;2(7):837-44. DOI: 10.1128/mcb.2.7.837-844.1982

Helle F, Brochot E, Handala L, Martin E, Castelain S, Francois C et al. Biology of the BKPyV: An Update. Viruses. 2017; 9(11). DOI: 10.3390/v9110327

Abend JR, Joseph AE, Das D, Campbell-Cecen DB, Imperiale MJ. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. The Journal of general virology. 2009;90(Pt 5):1238-45.

DOI: 10.1099/vir.0.009159-0

Seamone ME, Wang W, Acott P, Beck PL, Tibbles LA, Muruve DA. MAP kinase activation increases BK polyomavirus replication and facilitates viral propagation in vitro. Journal of virological methods. 2010;170(1-2):21-9.

DOI: 10.1016/j.jviromet.2010.08.014.

Liacini A, Seamone ME, Muruve DA, Tibbles LA. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: Toward a new therapy for BK virus infection. Transplantation. 2010; 90(12):1450-7.

DOI: 10.1097/TP.0b013e3182007be2.

Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993; 75(4):805-16. DOI: 10.1016/0092-8674(93)90499-g.

Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer research. 1991;51(23 Pt 1):6304-11.

Vousden KH, Lu X. Live or let die: the cell's response to p53. Nature reviews Cancer. 2002;2(8):594-604.

DOI: 10.1038/nrc864.

Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Jr., Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Molecular and Cellular Biology. 1994;14(9):6264-77. DOI: 10.1128/mcb.14.9.6264-6277.1994

Stewart ZA, Mays D, Pietenpol JA. Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Research. 1999;59(15):3831-7.

el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nature genetics. 1992;1(1):45-9. DOI: 10.1038/ng0492-45

Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. The Journal of Biological Chemistry. 1998; 273(1):1-4. DOI: 10.1074/jbc.273.1.1

Sellers WR, Kaelin WG. RB [corrected] as a modulator of transcription. Biochimica et Biophysica Acta. 1996;1288(1):M1- 5. DOI: 10.1016/0304-419x(96)00014-5

Wang JYJ. Retinoblastoma protein in growth suppression and death protection. Current Opinion in Genetics & Development. 1997;7(1):39-45. DOI: https://doi.org/10.1016/S0959-437X(97)80107-4

Tikhanovich I, Nasheuer HP. Host-specific replication of BK virus DNA in mouse cell extracts is independently controlled by DNA polymerase alpha-primase and inhibitory activities. Journal of Virology. 2010;84(13):6636-44.

DOI: 10.1128/jvi.00527-10

Tikhanovich I, Liang B, Seoighe C, Folk WR, Nasheuer HP. Inhibition of human BK polyomavirus replication by small noncoding RNAs. Journal of Virology. 2011;85(14):6930-40. DOI: 10.1128/jvi.00547-11

Cho US, Morrone S, Sablina AA, Arroyo JD, Hahn WC, Xu W. Structural basis of PP2A inhibition by small t antigen. PLoS Biology. 2007;5(8):e202. DOI: 10.1371/journal.pbio.0050202

Goodarzi AA, Jonnalagadda JC, Douglas P, Young D, Ye R, Moorhead GB et al. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. The EMBO Journal. 2004;23(22):4451-61.

DOI: 10.1038/sj.emboj.7600455

Kalev P, Simicek M, Vazquez I, Munck S, Chen L, Soin T et al. Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibition. Cancer Research. 2012; 72(24):6414-24.

DOI: 10.1158/0008-5472.can-12-1667

Slupe AM, Merrill RA, Strack S. Determinants for Substrate Specificity of Protein Phosphatase 2A. Enzyme Research. 2011;2011:398751. DOI: 10.4061/2011/398751

Liu H, Rankin S, Yu H. Phosphorylation-enabled binding of SGO1-PP2A to cohesin protects sororin and centromeric cohesion during mitosis. Nature cell Biology. 2013;15(1):40-9. DOI: 10.1038/ncb2637

Yaakov G, Thorn K, Morgan DO. Separase biosensor reveals that cohesin cleavage timing depends on phosphatase PP2A(Cdc55) regulation. Developmental Cell. 2012;23(1):124-36. DOI: 10.1016/j.devcel.2012.06.007

Li HH, Cai X, Shouse GP, Piluso LG, Liu X. A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55. The EMBO Journal. 2007;26(2): 402-11. DOI: 10.1038/sj.emboj.7601519

Lee HJ, Hwang HI, Jang YJ. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway. Cell cycle (Georgetown, Tex). 2010;9(12):2389-98. DOI: 10.4161/cc.9.12.11904

Wang L, Guo Q, Fisher LA, Liu D, Peng A. Regulation of polo-like kinase 1 by DNA damage and PP2A/B55α. Cell cycle (Georgetown, Tex). 2015;14(1):157-66. DOI: 10.4161/15384101.2014.986392

Wlodarchak N, Xing Y. PP2A as a master regulator of the cell cycle. Critical Reviews in Biochemistry and Molecular Biology. 2016;51(3):162-84. DOI: 10.3109/10409238.2016.1143913

He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, LT DC et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509-12.

Rimerman RA, Gellert-Randleman A, JA. D. Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation. Journal of Biological Chemistry. 2000;275(19):14736-42.

Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274-93.

DOI: 10.1016/j.cell.2012.03.017

Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nature reviews Drug Discovery. 2014; 13(2):140-56. DOI: 10.1038/nrd4204

Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circulation research. 2014;114(3):549-64. DOI: 10.1161/circresaha.114.302022

Chen J, Alberts I, Li X. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. International journal of developmental neuroscience : The official journal of the International Society for Developmental Neuroscience. 2014;35:35-41. DOI: 10.1016/j.ijdevneu.2014.03.006

Ugi S, Imamura T, Ricketts W, Olefsky JM. Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Molecular and cellular biology. 2002;22(7):2375- 87. DOI: 10.1128/mcb.22.7.2375-2387.2002

Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 1993;363(6424):45-51.

DOI: 10.1038/363045a0

Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut. 2003;52(1):144-51. DOI: 10.1136/gut.52.1.144

McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta. 2007;1773(8):1263-84.

DOI: 10.1016/j.bbamcr.2006.10.001

Meloche S, Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007; 26(22):3227-39. DOI: 10.1038/sj.onc.1210414

Imajo M, Tsuchiya Y, Nishida E. Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life. 2006;58(5-6):312-7. DOI: 10.1080/15216540600746393

Wu GS. Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Reviews. 2007;26(3-4):579-85. DOI: 10.1007/s10555-007-9079-6

Bollag B, Hofstetter CA, Reviriego-Mendoza MM, Frisque RJ. JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PloS One. 2010;5(5):e10606.

DOI: 10.1371/journal.pone.0010606

Wang W, Simmons DT. Simian Virus 40 Large T Antigen Can Specifically Unwind the Central Palindrome at the Origin of DNA Replication. Journal of Virology. 2009;83(7):3312-22. DOI: doi:10.1128/jvi.01867-08

Leung AYH, Chan MTL, Yuen K-Y, Cheng VCC, Chan K-H, Wong CLP et al. Ciprofloxacin Decreased Polyoma BK Virus Load in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Infectious Diseases. 2005;40(4):528-37. DOI: 10.1086/427291

Harris KF, Christensen JB, Radany EH, Imperiale MJ. Novel mechanisms of E2F induction by BK virus large-T antigen: requirement of both the pRb-binding and the J domains. Molecular and Cellular Biology. 1998;18(3):1746-56.

DOI: 10.1128/mcb.18.3.1746

Shivakumar CV, Das GC. Interaction of human polyomavirus BK with the tumor-suppressor protein p53. Oncogene. 1996; 13(2):323-32.

Harris KF, Christensen JB, Imperiale MJ. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. Journal of Virology. 1996; 70(4):2378-86.

DOI: 10.1128/jvi.70.4.2378-2386.1996

Agostini HT, Ryschkewitsch CF, Brubaker GR, Shao J, Stoner GI. Five complete genomes of JC virus type 3 from Africans and African Americans. Arch Virol. 1997;142(4):637-55. DOI: 10.1007/s007050050108

Cicala C, Avantaggiati ML, Graessmann A, Rundell K, Levine AS, Carbone M. Simian virus 40 small-t antigen stimulates viral DNA replication in permissive monkey cells. Journal of Virology. 1994;68(5):3138-44.

DOI: 10.1128/JVI.68.5.3138-3144.1994

Whalen B, Laffin J, Friedrich TD, Lehman JM. SV40 small T antigen enhances progression to >G2 during lytic infection. Experimental Cell Research. 1999;251(1): 121-7. DOI: 10.1006/excr.1999.4572

Teunissen EA, de Raad M, Mastrobattista E. Production and biomedical applications of virus-like particles derived from polyomaviruses. Journal of controlled release : official journal of the Controlled Release Society. 2013;172(1):305-21. DOI: 10.1016/j.jconrel.2013.08.026

Hurdiss DL, Morgan EL, Thompson RF, Prescott EL, Panou MM, Macdonald A et al. New Structural Insights into the Genome and Minor Capsid Proteins of BK Polyomavirus using Cryo-Electron Microscopy. Structure (London, England : 1993). 2016;24(4):528-36. DOI: 10.1016/j.str.2016.02.008

Morel V, Martin E, François C, Helle F, Faucher J, Mourez T et al. A Simple and Reliable Strategy for BK Virus Subtyping and Subgrouping. Journal of Clinical Microbiology. 2017;55(4):1177-85. DOI: 10.1128/jcm.01180-16

Fang CY, Chen HY, Wang M, Chen PL, Chang CF, Chen LS et al. Global analysis of modifications of the human BK virus structural proteins by LC-MS/MS. Virology. 2010;402(1):164-76. DOI: 10.1016/j.virol.2010.03.029

Henriksen S, Hansen T, Bruun JA, Rinaldo CH. The Presumed Polyomavirus Viroporin VP4 of Simian Virus 40 or Human BK Polyomavirus Is Not Required for Viral Progeny Release. Journal of Virology. 2016;90(22):10398-413.

DOI: 10.1128/jvi.01326-16

Chen PL, Hsu PH, Fang CY, Chang CF, Ou WC, Wang M et al. Phosphorylation of Ser-80 of VP1 and Ser-254 of VP2 is essential for human BK virus propagation in tissue culture. The Journal of General Virology. 2011;92(Pt 11):2637-45.

DOI: 10.1099/vir.0.033282-0

Rinaldo CH, Traavik T, Hey A. The agnogene of the human polyomavirus BK is expressed. Journal of Virology. 1998 ;72(7):6233-6. DOI: 10.1128/jvi.72.7.6233-6236.1998

Leuenberger D, Andresen PA, Gosert R, Binggeli S, Ström EH, Bodaghi S et al. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clinical and Vaccine Immunology: CVI. 2007;14(8): 959-68. DOI: 10.1128/cvi.00123-07

Johannessen M, Myhre MR, Dragset M, Tümmler C, Moens U. Phosphorylation of human polyomavirus BK agnoprotein at Ser-11 is mediated by PKC and has an important regulative function. Virology. 2008;379(1):97-109.

DOI: 10.1016/j.virol.2008.06.007

Unterstab G, Gosert R, Leuenberger D, Lorentz P, Rinaldo CH, Hirsch HH. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology. 2010; 399(2):322-31. DOI: 10.1016/j.virol.2010.01.011

Saribas AS, Arachea BT, White MK, Viola RE, Safak M. Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: Implications for their roles in agnoprotein function. Virology. 2011;420(1):51-65. DOI: 10.1016/j.virol.2011.08.015

Saribas AS, Coric P, Hamazaspyan A, Davis W, Axman R, White MK et al. Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses. Journal of Cellular Physiology. 2016;231(10):2115-27.

DOI: 10.1002/jcp.25329

Okada Y, Suzuki T, Sunden Y, Orba Y, Kose S, Imamoto N et al. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO reports. 2005;6(5):452-7. DOI: 10.1038/sj.embor.7400406

Gerits N, Johannessen M, Tümmler C, Walquist M, Kostenko S, Snapkov I et al. Agnoprotein of polyomavirus BK interacts with proliferating cell nuclear antigen and inhibits DNA replication. Virology Journal. 2015;12:7.

DOI: 10.1186/s12985-014-0220-1

Darbinyan A, Siddiqui KM, Slonina D, Darbinian N, Amini S, White MK et al. Role of JC virus agnoprotein in DNA repair. Journal of Virology. 2004;78(16):8593-600. DOI: 10.1128/JVI.78.16.8593-8600.2004

Gosert R, Rinaldo CH, Funk GA, Egli A, Ramos E, Drachenberg CB et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. The Journal of Experimental Medicine. 2008;205(4): 841-52.

DOI: 10.1084/jem.20072097

Seo GJ, Fink LH, O'Hara B, Atwood WJ, Sullivan CS. Evolutionarily conserved function of a viral microRNA. Journal of Virology. 2008;82(20):9823-8. DOI: 10.1128/jvi.01144-08

Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005;435(7042):682-6. DOI: 10.1038/nature03576

Broekema NM, Imperiale MJ. miRNA regulation of BK polyomavirus replication during early infection. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(20): 8200-5.

DOI: 10.1073/pnas.1301907110

Low J, Humes HD, Szczypka M, Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology. 2004;323(2):182-8. DOI: 10.1016/j.virol.2004.03.027

Jarzyński A, Zając P, Żebrowski R, Boguszewska A, Polz-Dacewicz M. Occurrence of BK Virus and Human Papilloma Virus in colorectal cancer. Annals of agricultural and environmental medicine: AAEM. 2017;24(3):440-5.

DOI: 10.26444/aaem/74648

Weinreb DB, Desman GT, Amolat-Apiado MJM, Burstein DE, Godbold Jr. JH, Johnson EM. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagnostic Cytopathology. 2006;34(3):201-3. DOI: https://doi.org/10.1002/dc.20429

Toptan T, Yousem SA, Ho J, Matsushima Y, Stabile LP, Fernández-Figueras MT et al. Survey for human polyomaviruses in cancer. JCI insight. 2016;1(2). DOI: 10.1172/jci.insight.85562

Salim M, Masroor M, Parween S, Prajapati IP. An overview on human polyomaviruses developing cancer in humans. The Journal of Medical Research. 2020;6:125-7. DOI: 10.31254/jmr.2020.6404

Al-Bayati AMS, Sulaiman ZM, Sulaiman MM, Alazzawy MA. Possible Role of BK Polyomavirus in Prostate Cancer. Indian Journal of Public Health Research & Development. 2019;10(10):1628.DOI: 10.5958/0976-5506.2019.03074.2

Carter JJ, Madeleine MM, Wipf GC, Garcea RL, Pipkin PA, Minor PD et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. Journal of the National Cancer Institute. 2003;95(20):1522-30.

DOI: 10.1093/jnci/djg074

Newton R, Ribeiro T, Alvarez E, Ziegler J, Casabonne D, Carpenter L et al. BK virus and cancer in Uganda. European journal of cancer prevention: The official journal of the European Cancer Prevention Organisation (ECP). 2006;15(4):285-9. DOI: 10.1097/00008469-200608000-00002

Newton R, Ribeiro T, Casabonne D, Alvarez E, Touzé A, Key T et al. Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort. British Journal of Cancer. 2005;93(11):1305-6.

DOI: 10.1038/sj.bjc.6602869

Das D, Shah RB, Imperiale MJ. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene. 2004;23(42):7031- 46. DOI: 10.1038/sj.onc.1207920

Das D, Wojno K, Imperiale MJ. BK virus as a cofactor in the etiology of prostate cancer in its early stages. Journal of Virology. 2008;82(6):2705-14. DOI: 10.1128/JVI.02461-07

Fioriti D, Russo G, Mischitelli M, Anzivino E, Bellizzi A, Di Monaco F et al. A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression? International Journal of Immunopathology and Pharmacology. 2007;20(2):405-11.

DOI: 10.1177/039463200702000223

Mischitelli M. Human Polymaviruses BK and Molecular action in Prostate Cancer development: Result, Quuestions, Perspectives of a Four Year long study, Italy. University of Siena; 2011.

Pater A, Pater MM. Transformation of primary human embryonic kidney cells to anchorage independence by a combination of BK virus DNA and the Harvey-ras oncogene. Journal of Virology. 1986; 58(2):680-3.

DOI: 10.1128/jvi.58.2.680-683.1986

Trabanelli C, Corallini A, Gruppioni R, Sensi A, Bonfatti A, Campioni D et al. Chromosomal aberrations induced by BK virus T antigen in human fibroblasts. Virology. 1998;243(2):492-6. DOI: 10.1006/viro.1998.9080

Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer research. 2008;68(4):1022-9. DOI: 10.1158/0008-5472.CAN-07-5203

Fioriti D, Pietropaolo V, Dal Forno S, Laurenti C, Chiarini F, Degener AM. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. International journal of immunopathology and pharmacology. 2003;16(3):283-8. DOI: 10.1177/039463200301600315

Imperiale MJ. Oncogenic transformation by the human polyomaviruses. Oncogene. 2001;20(54):7917-23.

DOI: 10.1038/sj.onc.1204916

Sontag E, Fedorov S, Kamibayashi C, Robbins D, Cobb M, Mumby M. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell. 1993;75(5):887-97. DOI: 10.1016/0092-8674(93)90533-v

McCabe MT, Low JA, Imperiale MJ, Day ML. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway. Oncogene. 2006;25(19):2727-35. DOI: 10.1038/sj.onc.1209266

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.

DOI: 10.1016/j.cell.2011.02.013

Moens U, Van Ghelue M, Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cellular and molecular life sciences : CMLS. 2007;64(13):1656-78. DOI: 10.1007/s00018-007-7020-3

Dalianis T, HH. H. BK polyomavirus and transformation Dalianis. In: ES R, editor. Cancer Associated Viruses. New York: Springer Science and Business Media, LLC. 2012;419-32.

Atencio IA, Shadan FF, Zhou XJ, Vaziri ND, Villarreal LP. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. Journal of Virology. 1993;67(3):1424-32. DOI: 10.1128/JVI.67.3.1424-1432.1993

Mitterhofer AP, Tinti F, Pietropaolo V, Barile M, Chiarini F, Meçule A et al. Polyomavirus BK replication in adult polycystic kidney disease post-renal transplant patients and possible role of cellular permissivity. Transplantation Proceedings. 2011;43(4):1048-51. DOI: 10.1016/j.transproceed.2011.02.046

Monini P, Rotola A, Di Luca D, De Lellis L, Chiari E, Corallini A et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology. 1995;214(1):273-9. DOI: 10.1006/viro.1995.9928

Alexiev BA, Randhawa P, Vazquez Martul E, Zeng G, Luo C, Ramos E et al. BK virus-associated urinary bladder carcinoma in transplant recipients: Report of 2 cases, review of the literature, and proposed pathogenetic model. Human Pathology. 2013;44(5):908-17. DOI: 10.1016/j.humpath.2012.09.019

Kawatani M, Imoto M. Deletion of the BH1 Domain of Bcl-2 Accelerates Apoptosis by Acting in a Dominant Negative Fashion*. Journal of Biological Chemistry. 2003; 278(22):19732-42.

DOI: https://doi.org/10.1074/jbc.M213038200

Carbone M, Burck C, Rdzanek M, Rudzinski J, Cutrone R, Bocchetta M. Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation. Cancer Research. 2003;63(19):6125-9.

Foddis R, De Rienzo A, Broccoli D, Bocchetta M, Stekala E, Rizzo P et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene. 2002;21(9):1434-42. DOI: 10.1038/sj.onc.1205203

Catalano A, Romano M, Martinotti S, Procopio A. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Oncogene. 2002;21(18):2896-900. DOI: 10.1038/sj.onc.1205382